Response to recent commentaries regarding the involvement of a<scp>ngiotensin‐converting</scp> enzyme 2 (<scp>ACE2</scp>) and <scp>renin‐angiotensin</scp> system blockers in <scp>SARS‐CoV</scp>‐2 infections
Robert C. Speth
Topics & Concepts
PharmacyLibrary scienceMedicinePharmacologyFamily medicineComputer scienceSARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesComputational Drug Discovery Methods